Vertex Pharmaceuticals is capturing the attention of investors with its expansion into pain management and cell/gene therapies. With positive earnings ...
AcelRx Pharmaceuticals rebrands as Talphera, expanding its therapeutic focus beyond acute pain management. Talphera aims to lead with innovative therapies ...